Skip to main content
. Author manuscript; available in PMC: 2010 Nov 1.
Published in final edited form as: Curr Hypertens Rev. 2009 Nov;5(4):283–306. doi: 10.2174/157340209789587717

Table 5.

Estrogen and estrogen-progestin products approved by US Food and Drug Administration (FDA) for postmenopausal women

Product Chemistry Dosage
ORAL
Angeliq® Tablets
estradiol - drospirenone 1 mg estradiol - 0.5mg drospirenone
Enjuvia™ Synthetic conjugated
estrogens
0.625 mg and 1.25 mg
Femhrt® Norethindrone acetate/
ethinyl estradiol
0.5 mg/2.5 microg
0.5 mg/5 microg
Prefest™ Estradiol/norgestimate 1.0 mg/d and 0.09mg/d
Premarin® CEE 0.3, 0.4, 0.625, 0.9 and 1.25 mg
Prempro™ CEE/MPA 0.3 mg/1.5 mg, 0.45mg/1.5 mg
0.625 mg/2.5 mg, 0.625 mg/5 mg
TRANSDERMAL
Alora®
Estradiol 0.025, 0.05, 0.075, 0.1 mg per day
Climara Pro™ Estradiol/Levonorgestrel 0.045 mg/d and 0.015 mg/d
CombiPatch® Estradiol/norethindrone
acetate (NETA)
0.05 mg/d estradiol and 0.14 mg/d NETA
0.05 mg/d estradiol and 0.25 mg/d NETA
Estraderm® Estradiol 0.05 or 0.1 mg per day
Menostar® Estradiol 14 microg per 7days
Vivelle®, Vivelle-Dot® Estradiol 0.025, 0.0375, 0.05, 0.075, or 0.1mg
TOPICAL EMULSION
Estrasorb™
Estradiol 0.05 mg/d
INJECTION
Delestrogen®
Estradiol valerate 10 mg every other week
Premarin® CEE 25 mg
VAGINAL
Femring®
Estradiol acetate 0.05 mg/d and 0.10 mg/d
Premarin® CEE 0.625 mg